# Precision Interception of Aggressive Prostate Cancer in African American Men

> **NIH NIH P20** · DANA-FARBER CANCER INST · 2020 · $73,247

## Abstract

SUMMARY
The goal of the MADCaP Collective Impact Developmental Research Program (CIDRP) is to develop
approaches that will facilitate the implementation and dissemination of our translational research projects to
impact on prostate cancer disparities in communities of need. Collective Impact refers to the commitment of
a group of important actors from different sectors to adopt a common agenda for solving a specified problem; it
can support many types of engagement with diverse stakeholders. These developmental pilots will work in
parallel with the three research projects to foster research of the highest quality and potential for clinical
applications, inspire groundbreaking ideas, and to promote the transition of pilot studies with the highest
translational potential into a full SPORE application after three years. The CIDRP will accomplish the following
Specific Aims: Specific Aim 1: To attract, select and fund research proposals with the highest potential to
benefit African American men with prostate cancer; Specific Aim 2: To conceive and implement processes for
the review of pilot projects, monitor their scientific progress, and ensure that the research developed in the
three P20 projects will be implemented in communities of African American men to lessen prostate cancer
disparities.
The focus of the program is to fund highly innovative investigators and studies that will allow our translational
research to have impact in communities of need. Nurturing the development and progress of pilot projects
through financial support, mentoring, and opportunities for collaborative interactions serves to expand the vigor
of our prostate cancer research program. We focus on developmental activities that will specifically support
implementation and dissemination research of highest potential gain and translational impact. The CIDRP is
directed by Dr. Grace Lu-Yao, Professor at Thomas Jefferson University. Dr. Lu-Yao is also a Co-Investigator
on Project 2 and therefore well integrated with the SPORE. Our External Advisory Board, the Community,
Clinical, and Scientific Advisory Board (CCSAB), will oversee the process of identifying the highest impact
developmental projects, ensure they link with the three research projects, and monitor their progress and
impact. This committee has been chosen to oversee the CIDRP process because it consists of a
multidisciplinary team with expertise in all of the relevant areas needed to achieve the required translational
objectives.
The program will provide funding for 1 to 2 years for meritorious projects that complement or enhance the main
research activities in the area of prostate cancer. These projects may focus on basic or translational biological
science, applied science, clinical studies or initiatives intended to create shared resources that will enhance the
research infrastructure of our Institutions. Pilot projects will be supported for 1-2 years at a level of $50,000-
$100,000 per year using both P20 and ins...

## Key facts

- **NIH application ID:** 9994869
- **Project number:** 5P20CA233255-03
- **Recipient organization:** DANA-FARBER CANCER INST
- **Principal Investigator:** Grace Lu-Yao
- **Activity code:** P20 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $73,247
- **Award type:** 5
- **Project period:** — → 2022-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9994869

## Citation

> US National Institutes of Health, RePORTER application 9994869, Precision Interception of Aggressive Prostate Cancer in African American Men (5P20CA233255-03). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/9994869. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*